
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
Jeremy Kean Yi Yap, Miyu Moriyama, Akiko Iwasaki
The Journal of Immunology (2020) Vol. 205, Iss. 2, pp. 307-312
Open Access | Times Cited: 247
Jeremy Kean Yi Yap, Miyu Moriyama, Akiko Iwasaki
The Journal of Immunology (2020) Vol. 205, Iss. 2, pp. 307-312
Open Access | Times Cited: 247
Showing 1-25 of 247 citing articles:
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas, Patrick Wong, Jon Klein, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 463-469
Open Access | Times Cited: 2021
Carolina Lucas, Patrick Wong, Jon Klein, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 463-469
Open Access | Times Cited: 2021
Immunopathology of Hyperinflammation in COVID-19
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
Multi-organ proteomic landscape of COVID-19 autopsies
Xiu Nie, Liujia Qian, Rui Sun, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 775-791.e14
Open Access | Times Cited: 357
Xiu Nie, Liujia Qian, Rui Sun, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 775-791.e14
Open Access | Times Cited: 357
Detection of Viral Infections by Innate Immunity
Michael Carty, Coralie Guy, Andrew Bowie
Biochemical Pharmacology (2020) Vol. 183, pp. 114316-114316
Open Access | Times Cited: 295
Michael Carty, Coralie Guy, Andrew Bowie
Biochemical Pharmacology (2020) Vol. 183, pp. 114316-114316
Open Access | Times Cited: 295
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 288
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 288
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 245
André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 245
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
Peijie Zhong, Jing Xu, Dong Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 185
Peijie Zhong, Jing Xu, Dong Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 185
A Bibliometric Analysis of Pyroptosis From 2001 to 2021
Dan Ma, Bin Yang, Baoyi Guan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 168
Dan Ma, Bin Yang, Baoyi Guan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 168
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162
The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences
Tayrine Ordonio Filgueira, Ângela Castoldi, Lucas Eduardo Rodrigues Santos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 130
Tayrine Ordonio Filgueira, Ângela Castoldi, Lucas Eduardo Rodrigues Santos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 130
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells
Rémi Planès, Miriam Pinilla, Karin Santoni, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2385-2400.e9
Open Access | Times Cited: 103
Rémi Planès, Miriam Pinilla, Karin Santoni, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2385-2400.e9
Open Access | Times Cited: 103
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors
Zhen Dai, Wan-Cong Liu, Xiaoyi Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Zhen Dai, Wan-Cong Liu, Xiaoyi Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
A distinct innate immune signature marks progression from mild to severe COVID-19
Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, et al.
Cell Reports Medicine (2020) Vol. 2, Iss. 1, pp. 100166-100166
Open Access | Times Cited: 132
Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, et al.
Cell Reports Medicine (2020) Vol. 2, Iss. 1, pp. 100166-100166
Open Access | Times Cited: 132
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
Nurit P. Azouz, Andrea M. Klingler, Victoria Callahan, et al.
Pathogens and Immunity (2021) Vol. 6, Iss. 1, pp. 55-74
Open Access | Times Cited: 99
Nurit P. Azouz, Andrea M. Klingler, Victoria Callahan, et al.
Pathogens and Immunity (2021) Vol. 6, Iss. 1, pp. 55-74
Open Access | Times Cited: 99
COVID-19: neonatal–perinatal perspectives
Alejandra Barrero-Castillero, Kristyn Beam, Laura B. Bernardini, et al.
Journal of Perinatology (2020) Vol. 41, Iss. 5, pp. 940-951
Open Access | Times Cited: 85
Alejandra Barrero-Castillero, Kristyn Beam, Laura B. Bernardini, et al.
Journal of Perinatology (2020) Vol. 41, Iss. 5, pp. 940-951
Open Access | Times Cited: 85
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Ali Attiq, Lui Jin Yao, Sheryar Afzal, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108255-108255
Open Access | Times Cited: 78
Ali Attiq, Lui Jin Yao, Sheryar Afzal, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108255-108255
Open Access | Times Cited: 78
Rationale for azithromycin in COVID-19: an overview of existing evidence
Iwein Gyselinck, Wim Janssens, Peter Verhamme, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e000806-e000806
Open Access | Times Cited: 72
Iwein Gyselinck, Wim Janssens, Peter Verhamme, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e000806-e000806
Open Access | Times Cited: 72
Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication
Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, et al.
Cytokine (2021) Vol. 142, pp. 155496-155496
Open Access | Times Cited: 69
Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, et al.
Cytokine (2021) Vol. 142, pp. 155496-155496
Open Access | Times Cited: 69
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
Alan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Alan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Cell pyroptosis in health and inflammatory diseases
Yongqi Wu, Jing Zhang, Sihui Yu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Yongqi Wu, Jing Zhang, Sihui Yu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis
Huang Kai, Catherine Wang, Christen Vagts, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261242-e0261242
Open Access | Times Cited: 61
Huang Kai, Catherine Wang, Christen Vagts, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261242-e0261242
Open Access | Times Cited: 61
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 60
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 60
An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
Katherine C. Barnett, Yuying Xie, Takanori Asakura, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 2, pp. 243-259.e6
Open Access | Times Cited: 52
Katherine C. Barnett, Yuying Xie, Takanori Asakura, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 2, pp. 243-259.e6
Open Access | Times Cited: 52
Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates
Jacqueline Corry, Gwenddolen Kettenburg, Amit A. Upadhyay, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010395-e1010395
Open Access | Times Cited: 41
Jacqueline Corry, Gwenddolen Kettenburg, Amit A. Upadhyay, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010395-e1010395
Open Access | Times Cited: 41